DoW Lupus, Idea Award
The summary for the DoW Lupus, Idea Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept. of the Army -- USAMRAA, which is the U.S. government agency offering this grant.
DoW Lupus, Idea Award: Summary: This funding mechanism supports innovative, high-risk/high-reward research that could ultimately lead to a critical discovery or major advancement relevant to lupus. The emphasis is on innovation. Research must address at least one of the fiscal year 2026 (FY26) Lupus Research Program (LRP) Idea Award (IA) focus areas. This funding mechanism does not allow clinical trials.Distinctive Features:• Early-career investigators are eligible to serve as Principal Investigators (PIs) on applications to the FY26 LRP Idea Award (see Section 2. Eligibility Information).• Preliminary data are permitted but not required.• Applications should describe future directions of the work.• An individual may be named as PI on only one application per LRP award mechanism (IA, Impact Award, Transformative Vision Development Award, Transformative Vision Award), for a maximum of four applications to the FY26 LRP
| Federal Grant Title: | DoW Lupus, Idea Award |
| Federal Agency Name: | Dept. of the Army -- USAMRAA (DOD-AMRAA) |
| Grant Categories: | Science and Technology and other Research and Development |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | HT942526LRPIA |
| Type of Funding: | Grant |
| CFDA Numbers: | 12.420 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | August 24th, 2026 |
| Original Application Deadline: | August 24th, 2026 |
| Posted Date: | May 5th, 2026 |
| Creation Date: | May 5th, 2026 |
| Archive Date: | September 23rd, 2026 |
| Total Program Funding: | $1,500,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | No |
| Last Updated: | May 5th, 2026 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
eBRAP Help Desk - Similar Government Grants
- • DoW Breast Cancer, Breakthrough Award Levels 1 and 2
- • DoW Breast Cancer, Clinical Research Extension Award
- • DoW Reconstructive Transplant, Investigator-Initiated Research Award
- • DoW Neurofibromatosis Exploration-Hypothesis Development Award
- • DoW Neurofibromatosis Research Academy - Scholar Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept. of the Army -- USAMRAA
- • DoW Bone Marrow Failure, Resource Development Award
- • DoW Joint Warfighter Medical, Military Medical Research and Development Award
- • DoW Rare Cancers Resource and Community Development Award
- • DoW Duchenne Muscular Dystrophy Clinical/Translational Award
- • DoW Duchenne Muscular Dystrophy, Idea Development Award
